Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study

Figure 3

mTOR activity in human Hodgkin-lymphoma biopsies. a. High (A) and low (B) mTOR activity in lymphoma cells of Hodgkin-lymphoma biopsies. Low mTOR activity is comparable to that of reactive lymph nodes (C). (pS6 IHC; representative examples are shown.) b. Kaplan-Meier survival curves stratified by mTOR activity: low mTOR and high mTOR groups include 6 and 77 cases respectively (p=0.42).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us